adenine has been researched along with canagliflozin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, AM; Adham, SA; Al Salam, S; Al Suleimani, Y; Al Za'abi, M; Ali, BH; Ashique, M; Hartmann, C; Manoj, P; Nemmar, A; Schupp, N | 1 |
| Corremans, R; D'Haese, PC; De Broe, ME; Leysen, H; Maudsley, S; Neven, E; Verhulst, A; Vervaet, BA | 1 |
2 other study(ies) available for adenine and canagliflozin
| Article | Year |
|---|---|
Effects of the SGLT-2 Inhibitor Canagliflozin on Adenine-Induced Chronic Kidney Disease in Rats.
Topics: Adenine; Animals; Biomarkers; Canagliflozin; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats.
Topics: Adenine; Animals; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Metformin; Proteomics; Rats; Renal Insufficiency, Chronic | 2022 |